Correspondence 0001193125-23-300167 from Beneficient (BENF)
Beneficient
Date: Dec. 20, 2023 · CIK: 0001775734 · Accession: 0001193125-23-300167
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275174
Referenced dates: December 14, 2023
Letter
December 20, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Division of Corporation Finance
Officer of Finance
Washington, D.C. 20549
Attention: Robert Arzonetti and Christian Windsor
Re:
Beneficient
Amendment No. 1 to Registration Statement on Form S-1
Filed December 4, 2023
File No. 333-275174
Ladies and Gentlemen:
On behalf of Beneficient (the “Company”), below is the response of the Company to the comments of the staff of the Division of Corporation Finance (the “Staff”) of the United States Securities and Exchange Commission (the “Commission”) set forth in the Staff’s letter, dated December 14, 2023, regarding the Company’s Amendment No. 1 to the Registration Statement on Form S-1 (the “Registration Statement”) filed with the Commission on December 4, 2023. In connection with this letter, an amendment to the Registration Statement (“Amendment No. 2”) has been submitted to the Commission on the date hereof.
For your convenience, the Staff’s comments are set forth in bold, followed by responses on behalf of the Company. Unless otherwise indicated, all page references in the responses set forth below are to the pages of the clean copy of Amendment No. 2. Capitalized terms used but not otherwise defined herein shall have the meanings assigned to such terms in Amendment No. 2.
Amendment No. 1 to the Registration Statement on Form S-1 filed on December 4, 2023
Management’s Discussion and Analysis
Liquidity and Capital Resources, page 162
1.
We note your response to comment 5 and reissue in part. Please revise your disclosure to clarify whether the Credit and Guarantee Agreement with HH-BDH impacts your ability to meet your expected funding needs.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on pages 162 and 163 of Amendment No. 2 accordingly.
* * * * * *
2801 N. Harwood Street | Suite 2300 | Dallas, TX 75201
T: 214.651.5000 | haynesboone.com
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Finance
December 20, 2023
Page
If you have any questions or require any additional information in connection with the filing, please do not hesitate to contact the undersigned at (214) 651-5443.
Very truly yours,
/s/ Matthew L. Fry
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
December 20, 2023
VIA EDGAR
U.S. Securities and Exchange
Commission
100 F Street, N.E.
Division of Corporation
Finance
Officer of Finance
Washington, D.C. 20549
Attention: Robert Arzonetti and Christian Windsor
Re:
Beneficient
Amendment
No. 1 to Registration Statement on Form S-1
Filed December 4, 2023
File No. 333-275174
Ladies and Gentlemen:
On behalf of Beneficient (the “Company”), below is the response of the Company to the comments of the staff of the Division of
Corporation Finance (the “Staff”) of the United States Securities and Exchange Commission (the “Commission”) set forth in the Staff’s letter, dated December 14, 2023, regarding the Company’s Amendment No. 1 to
the Registration Statement on Form S-1 (the “Registration Statement”) filed with the Commission on December 4, 2023. In connection with this letter, an amendment to the Registration Statement (“Amendment No. 2”)
has been submitted to the Commission on the date hereof.
For your convenience, the Staff’s comments are set forth in bold, followed
by responses on behalf of the Company. Unless otherwise indicated, all page references in the responses set forth below are to the pages of the clean copy of Amendment No. 2. Capitalized terms used but not otherwise defined herein
shall have the meanings assigned to such terms in Amendment No. 2.
Amendment No. 1 to the Registration Statement on Form S-1 filed on December 4, 2023
Management’s Discussion and Analysis
Liquidity and Capital Resources, page 162
1.
We note your response to comment 5 and reissue in part. Please revise your disclosure to clarify whether the Credit and Guarantee Agreement with HH-BDH impacts your ability to meet your
expected funding needs.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on pages 162
and 163 of Amendment No. 2 accordingly.
* * * *
* *
2801 N. Harwood Street | Suite 2300 | Dallas, TX 75201
T: 214.651.5000 | haynesboone.com
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Finance
December 20, 2023
Page
2
If you have any
questions or require any additional information in connection with the filing, please do not hesitate to contact the undersigned at (214) 651-5443.
Very truly yours,
/s/ Matthew L. Fry
Matthew L. Fry
Haynes and Boone,
LLP
cc:
Brad K. Heppner, Chief Executive Officer
Gregory W. Ezell, Chief Financial Officer
James G. Silk, Esq., Chief Legal Officer
David B. Rost, Esq., General Counsel
Logan Weissler, Esq., Haynes and Boone, LLP
Alexa Cooper, Esq., Haynes and Boone, LLP